| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| TEVA Teva Pharmaceutical Industries Limited | 119,822,128,379.3 | 451,095,071,545.6 | 1,306,634,903,095.42 |
| BHC Bausch Health Companies Inc. | 81,465,934,069.1 | 242,856,997,820.48 | 835,443,808,377.04 |
| RDY Dr. Reddy's Laboratories Limited | 4,466,407,699.79 | 101,612,482,512.54 | 196,167,153,041.37 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| BBIO BridgeBio Pharma, Inc. | 50,268,349,723.14 | 67,028,465,832.31 | 70,869,986,216.3 |
| AMPH Amphastar Pharmaceuticals, Inc. | 7,330,753,875.62 | 20,684,512,099.33 | 57,166,006,433.78 |
| 6472 保瑞 | 8,431,018,000 | 24,395,699,000 | 52,077,131,000 |
| SUPN Supernus, Inc. | 9,998,836,978.3 | 26,226,457,648.0 | 43,667,051,983.92 |
| TSHA Taysha Gene Therapies, Inc. | 14,929,640,497.63 | 15,127,224,072.93 | 15,422,238,938.4 |
| 3705 永信 | 1,681,311,000 | 7,568,539,000 | 13,176,178,000 |
| 1720 生達 | 2,014,373,000 | 5,775,065,000 | 12,315,901,000 |
| 4120 友華 | 1,545,691,000 | 4,035,955,000 | 11,750,301,000 |
| ASMB Assembly Biosciences Inc | 1,058,434,264.53 | 10,752,126,408.09 | 10,845,689,295.75 |
| PSNL Personalis, Inc. | 3,080,559,715.33 | 8,033,557,374.45 | 10,232,744,197.45 |
| 4747 強生* | 261,729,000 | 602,886,000 | 2,558,703,000 |
| 6461 益得 | 95,420,000 | 370,571,000 | 2,295,483,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | 546,231,546.66 | 1,674,592,103.9 | 1,762,286,821.66 |
| CPHI China Pharma Holdings Inc | 9,994,575.18 | 65,783,168.06 | 1,465,727,873.5 |
| 6130 上亞科技 | 75,442,000 | 178,444,000 | 735,886,000 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例